Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemigliptin add-on to glimepiride and metformin in T2DM
NCT01990469Phase 3Completed
- Sponsor
- LG Chem
- Start
- Jan 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gemigliptin in type 2 diabetes mellitus (T2DM), sponsored by LG Chem. Started Jan 2014; status: completed.
02
Drugs
gemigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01990469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01990469.